Global Tiotropium Bromide Market 2023-2030

    In Stock

    Coming Soon




    Tiotropium bromide is a long-acting bronchodilator LAMA: long acting muscarinic antagonist used in the treatment of chronic obstructive pulmonary disease and asthma. It is utilised through mouth inhalation. In most cases, onset starts within a half-hour and lasts for 24 hours.


    Angioedema, increasing bronchospasm, and QT prolongation are examples of severe adverse effects. Since such use has not been thoroughly researched, preliminary evidence does not indicate risk during pregnancy. It is an anticholinergic drug that prevents smooth muscle from being affected by acetylcholine.


    Tiotropium is used to treat chronic obstructive pulmonary disease on an ongoing basis. Those with moderate to severe asthma who are taking medium to high doses of inhaled corticosteroids may also use it as an adjunctive therapy.


    However, it is not recommended for sudden worsening of asthma or sudden exacerbations of COPD Olodaterol, a long-acting beta-agonist, and tiotropium are other combined inhalers used to treat COPD.


    Tiotropium, sometimes known as antimuscarinic or anticholinergic medication, is a muscarinic receptor antagonist. When applied topically, it mostly affects M3 muscarinic receptors found on smooth muscle cells and submucosal glands, despite the fact that it does not exhibit selectivity for certain muscarinic receptors.


    This results in a decrease in mucus output and smooth muscle contraction, which has the bronchodilator effect. Its antimuscarinic properties are primarily responsible for any negative effects.


    Dry mouth and/or throat discomfort are typical adverse medication effects. Urinary retention, constipation, acute angle closure glaucoma, palpitations, particularly supraventricular tachycardia and atrial fibrillation, allergies, and other conditions are uncommonly treated.




    infographic: Tiotropium Bromide Market , Tiotropium Bromide Market Size, Tiotropium Bromide Market Trends, Tiotropium Bromide Market Forecast, Tiotropium Bromide Market Risks, Tiotropium Bromide Market Report, Tiotropium Bromide Market Share


    The Global Tiotropium bromide Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.



    Under the trade name Tiogiva, Glenmark has launched the tiotropium bromide dry powder inhaler. Chronic lung inflammation, lung tissue destruction, and airway narrowing are all symptoms of COPD, which makes breathing challenging. There are numerous variations of the disorder, but little is known about what causes these variations and how to treat the various disease forms.





    1. How many Tiotropium bromide are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global Tiotropium bromide and key vendor selection criteria
    3. Where is the Tiotropium bromide manufactured? What is the average margin per unit?
    4. Market share of Global Tiotropium bromide market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global Tiotropium bromide in-house
    6. key predictions for next 5 years in Global Tiotropium bromide market
    7. Average B-2-B Tiotropium bromide market price in all segments
    8. Latest trends in Tiotropium bromide market, by every market segment
    9. The market size (both volume and value) of the Tiotropium bromide market in 2023-2030 and every year in between?
    10. Production breakup of Tiotropium bromide market, by suppliers and their OEM relationship


    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2023-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2023-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2023-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop